Modulatory effects of d-serine and sarcosine on NMDA receptor-mediated neurotransmission are apparent after stress in the genetically inbred BALB/c mouse strain

Brain Research Bulletin

Volumn 69, Issue 6, 2006, Pages 626-630

  Long, Katrice D ^a   Mastropaolo, John ^a   Rosse, Richard B ^a,b   Manaye, Kebreten F ^c   Deutsch, Stephen I ^a,b,c  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

BALB c inbred mouse strain; d Serine; NMDA receptor; Sarcosine; Schizophrenia; Seizures; Stress

Indexed keywords

AMINO ACID RECEPTOR AFFECTING AGENT; DEXTRO SERINE; DIZOCILPINE; GLUTAMIC ACID; GLYCINE RECEPTOR ANTAGONIST; IONOPHORE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SARCOSINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HINDLIMB; INBRED STRAIN; LIMB MOVEMENT; MALE; MOUSE; MOUSE STRAIN; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; STRESS;

ANALYSIS OF VARIANCE; ANIMALS; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICE; MICE, INBRED BALB C; RECEPTORS, N-METHYL-D-ASPARTATE; SARCOSINE; SEIZURES; SERINE; STRESS; SYNAPTIC TRANSMISSION;

EID: 33646592256     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2006.03.007     Document Type: Article

References (13)

1. Bresink I., Danysz W., Parsons C.G., and Mutschler E. Different binding affinities of NMDA receptor channel blockers in various brain regions-indication of NMDA receptor heterogeneity. Neuropharmacology 34 (1995) 533-540
2. Deutsch S.I., and Hitri A. Measurement of an explosive behavior in the mouse, induced by MK-801, a PCP analogue. Clin. Neuropharmacol. 16 3 (1993) 251-257
3. Deutsch S.I., Mastropaolo J., Powell D.G., Rosse R.B., and Bachus S.E. Inbred mouse strains differ in their sensitivity to an antiseizure effect of MK-801. Clin. Neuropharmacol. 21 4 (1998) 225-257
4. Deutsch S.I., Mastropaolo J., Schwartz B.L., et al. A 'glutamatergic hypothesis' of schizophrenia: rational for pharmacotherapy with glycine. Clin. Neuropharmacol. 12 (1989) 1-13
5. Deutsch S.I., Rosse R.B., and Mastropaolo J. Behavioral approaches to the functional assessment of NMDA-mediated neural transmission in intact mice. Clin. Neuropharmacol. 20 5 (1997) 375-384
6. Deutsch S.I., Rosse R.B., Paul S.M., Riggs R.L., and Mastropaolo J. Inbred mouse strains differ in sensitivity to "popping" behavior elicited by MK-801. Pharmacol. Biochem. Behav. 57 (1997) 315-317
7. Deutsch S.I., Rosse R.B., Paul S.M., Tomasino V., Koetzner L., Morn C.B., and Mastropaolo J. 7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in mice. Neuropsychopharmacology 15 1 July (1996) 37-43
8. Deutsch S.I., Rosse R.B., Schwartz B.L., Powell D.G., and Mastropaolo J. Stress and a glycinergic intervention interact in the modulation of MK-801-elicited mouse popping behavior. Pharmacol. Biochem. Behav. 62 2 (1999) 395-398
9. Javitt D., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry 148 (1991) 1301-1308
10. Lynch D.R., Anegawa N.J., Verdoorn T., and Pritchett D.B. N-Methyl-d-aspartate receptors: different requirements for binding of glutamate antagonists, glycine antagonists, and channel blocking agents. Mol. Pharmacol. 45 (1994) 540-545
11. Norris D.O., Mastropaolo J., O'Connor D.A., Cohen J.M., and Deutsch S.I. A glycinergic intervention potentiates the antiseizure efficacies of MK-801, flurazepam, and carbamazepine. Neurochem. Res. 19 (1994) 161-165
12. Norris D.O., Mastropaolo J., O'Connor D.A., Novitzki M., and Deutsch S.I. Glycinergic interventions potentiate the ability of MK-801 to raise the threshold voltage for tonic hindlimb extension in mice. Pharmacol. Biochem. Behav. 43 (1992) 609-612
13. Seyfried T.N., and Glaser G. A review of mouse mutants as genetic models of epilepsy. Epilepsia 26 (1985) 143-150